Diana N J Lockwood (Diana N Lockwood)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 5

Top Topics

Respiratory Syndrome Coronavirus

Randomized Controlled Trial

Affordable Care Act

Extracorporeal Membrane Oxygenation

Top Venues

PLoS neglected tropical diseases

Transactions of the Royal Society of Tropical Medicine and Hygiene

This page only lists publications with an associated author ORCID identifier.

Publications

Diana N J Lockwood, Amy McIntosh, Margaret Armstrong, Anna M Checkley, Stephen L Walker, Angela McBride
Diagnosing and treating leprosy in a non-endemic setting in a national centre, London, United Kingdom 1995-2018. PLoS neglected tropical diseases 16 (10) (2022)
Romain Guery, Stephen L Walker, Gundel Harms, Andreas Neumayr, Pieter Van Thiel, Jean-Pierre Gangneux, Jan Clerinx, Sara Karlsson Söbirk, Leo Visser, Laurence Lachaud, Mark S Bailey, Aldert Bart, Christophe Ravel, Gert Van der Auwera, Johannes Blum, Diana N J Lockwood, Pierre A Buffet, null null
Clinical diversity and treatment results in Tegumentary Leishmaniasis: A European clinical report in 459 patients. PLoS neglected tropical diseases 15 (10) (2021)
Barbara De Barros, Saba M Lambert, Diana N J Lockwood, Guillermo Robert de Arquer, Anna M Sales, Joydeepa Darlong, Vivianne L A Dias, Benjamin Jewel Rozario, Vivek V Pai, Medhi Denisa Alinda, Muhammad Yulianto Listiawan, Deanna A Hagge, Mahesh Shah, Diana N J Lockwood, Stephen L Walker
An assessment of the reported impact of the COVID-19 pandemic on leprosy services using an online survey of practitioners in leprosy referral centres. Transactions of the Royal Society of Tropical Medicine and Hygiene 115 (12) (2021)
Diana N J Lockwood, Padebettu Krishnamurthy, Bhushan Kumar, Gerson Penna
Single-dose rifampicin chemoprophylaxis protects those who need it least and is not a cost-effective intervention. PLoS neglected tropical diseases 12 (6) (2018)
Diana N J Lockwood, Joydeepa Darlong, Pitchaimani Govindharaj, Royce Kurian, Pamidipani Sundarrao, Annamma S John
AZALEP a randomized controlled trial of azathioprine to treat leprosy nerve damage and Type 1 reactions in India: Main findings. PLoS neglected tropical diseases 11 (3) (2017)